Executive Summary
This digest covers $1.18B in high-value federal contracts awarded on June 10, 2026, with a 2/5 defense-related split, though the largest award—a $777M CACI NSS delivery order for special operations support—dominates the aggregate.
The civilian side is led by a $125.5M Icahn School of Medicine CDC contract (now expired) and a $92.8M BARDA award to private firm Tunnell Consulting for biodefense R&D, signaling sustained biosecurity investment. The highest-conviction signal is the CACI award, which is bullish for defense services given its full-and-open competitive win and high-priority mission, but the cost-plus structure limits margin upside. Key risks include the negative outlay on the Amentum $91.7M GSA contract, suggesting funding timing uncertainty, and the expiration of the Icahn contract, which removes a revenue stream. Investors should watch for option exercises on CACI's $1.13B potential ceiling and Tunnell Consulting's long-dated BARDA options extending to 2035.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior High-Value Federal Grants ($5M+) digest from June 06, 2026.
Investment Signals (5)
- CACI Wins $777M Special Operations Support Contract, Validating Competitive Moat (HIGH)▲
CACI International Inc. won a $777M cost-plus award fee delivery order from GSA for Special Operations Forces Emerging Threats Operations and Planning Support at Fort Bragg, with options bringing total potential to $1.13B. The full-and-open competition with no set-aside confirms CACI's strong market position in this niche defense services area.
- Amentum Services Secures $91.7M GSA Engineering Contract with $211.9M Upside (MEDIUM)▲
Amentum Services, Inc. won a $91.7M delivery order from GSA for engineering and program management support, with options potentially increasing total to $211.9M. The full-and-open competitive award provides multi-year revenue visibility through mid-2025, though negative outlays (-$29k) warrant monitoring.
- Icahn School of Medicine CDC Contract Expired—$125.5M Revenue Stream Ended (HIGH)▲
The $125.5M cost-no-fee contract with the CDC for the World Trade Center Health Program Clinical Center of Excellence ended in 2022, with only $32.9M outlayed. This removes a stable, low-risk revenue source for the nonprofit, though no direct public equity impact.
- Tunnell Consulting's $660.2M BARDA Ceiling Signals Long-Term Biodefense Investment (MEDIUM)▲
Tunnell Consulting Inc. won a $92.8M delivery order from BARDA with a base-plus-options ceiling of $660.2M extending to 2035 for biotech R&D support. This signals sustained government commitment to biodefense and pandemic preparedness, though the company is private, limiting direct investment.
- Caltech JPL FFRDC Contract Non-Competitive—No Direct Public Investment Opportunity (LOW)▲
The $92.5M non-competitive, cost-plus-fixed-fee NASA delivery order to Caltech for JPL high-performance spaceflight computing R&D provides stable revenue but is not investable as Caltech is a private nonprofit. The award signals continued NASA space computing investment, which may benefit public contractors indirectly.
Risk Flags (4)
- Execution [MEDIUM RISK]▼
Amentum Services' $91.7M GSA contract shows negative outlays (-$29k), suggesting possible funding adjustments or payment delays that could impact cash flow timing and execution.
- Budget [MEDIUM RISK]▼
The CACI $777M contract's cost-plus structure limits margin upside and exposes the company to potential cost overruns or government audit risk, especially under a Continuing Resolution scenario that could delay option exercises.
- Concentration [MEDIUM RISK]▼
The digest shows two contracts (CACI $777M and Amentum $91.7M) both awarded by GSA, representing 73.5% of total obligation value. Over-reliance on GSA as a contracting vehicle could create vulnerability if GSA procurement policies shift or budgets are cut.
- Competition [LOW RISK]▼
The Icahn School of Medicine's $125.5M CDC contract has expired, and the re-compete for the World Trade Center Health Program Clinical Center of Excellence could go to a competitor, potentially shifting market share in healthcare services.
Opportunities (3)
- ◆
CACI's $777M special operations support contract positions the company for follow-on work in the high-priority SOF mission area. The $1.13B potential ceiling offers significant revenue upside if all options are exercised, reinforcing CACI's competitive moat in defense services.
- ◆
Tunnell Consulting's $92.8M BARDA award with a $660.2M ceiling extending to 2035 signals sustained government investment in biodefense and medical countermeasure R&D. If Tunnell goes public or is acquired, this contract provides a strong revenue base for investors.
- ◆
Amentum Services' $91.7M GSA contract with $211.9M potential ceiling offers multi-year revenue visibility through 2025. The full-and-open competitive win validates Amentum's market position in engineering and program management, and option exercises could drive upside.
Sector Themes (3)
- ◆
CACI's $777M contract for Special Operations Forces Emerging Threats Operations and Planning Support at Fort Bragg underscores the DOD's continued prioritization of SOF capabilities, a durable budget line item even under CR scenarios.
- ◆
Tunnell Consulting's $92.8M BARDA award with a $660.2M ceiling extending to 2035 reflects the government's long-term commitment to biodefense R&D, a theme accelerated by recent pandemic experiences.
- ◆
Two of the five contracts (CACI $777M and Amentum $91.7M) were awarded through GSA, representing 73.5% of total obligation value. This highlights GSA's role as a key procurement vehicle for defense and civilian professional services.
Watch List (4)
- 👁
{"entity"=>"CACI International Inc.", "reason"=>"Won the largest contract in the digest ($777M) with $1.13B potential ceiling for special operations support, a high-priority defense area.", "trigger"=>"Option exercise announcements for the $1.13B ceiling; quarterly revenue reports showing contract contribution"}
- 👁
{"entity"=>"Amentum Services, Inc.", "reason"=>"Negative outlays (-$29k) on $91.7M GSA contract suggest funding timing uncertainty; option exercises could drive upside.", "trigger"=>"Outlay direction resolution; option exercise timeline after current obligation"}
- 👁
{"entity"=>"Tunnell Consulting Inc.", "reason"=>"Private company with $660.2M BARDA ceiling extending to 2035; potential IPO or acquisition could create public equity opportunity.", "trigger"=>"Option exercise announcements; any news of IPO or acquisition"}
- 👁
{"entity"=>"Icahn School of Medicine at Mount Sinai", "reason"=>"Expired $125.5M CDC contract; re-compete for WTC Health Program could shift market share.", "trigger"=>"Follow-on contract announcements for World Trade Center Health Program Clinical Center of Excellence"}
Get daily alerts with 5 investment signals, 4 risk alerts, 3 opportunities and full AI analysis of all 5 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: High-Value Federal Grants ($5M+)
🇺🇸 More from United States
View all →June 12, 2026
US Pre-Market SEC Filings Roundup — June 12, 2026
US Pre-Market SEC Filings Roundup
June 12, 2026
S&P 500 Energy Sector SEC Filings — June 12, 2026
S&P 500 Energy Sector SEC Filings
June 12, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings — June 12, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings
June 12, 2026
US Executive Compensation Proxy SEC Filings — June 12, 2026
US Executive Compensation Proxy SEC Filings